Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Boston Bio Systems Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Boston Bio Systems Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Boston Bio Systems L - Non-Applicability Of Annual Secretarial Compliance Report For The Year Ended 31St March, 2025 Under Re

    30 May 2025, 5:09PM Non- Applicability of Annual Secretarial Compliance Report for the year ended 31st March 2025 under Regulation 24A
  • Boston Bio Systems L - Please Find Enclosed Herewith Audited Results Of The Company For The Financial Year Ended 31St March,

    30 May 2025, 4:20PM Please Find the Enclosed herewith Audited Results for FY 31 march 2025
  • Boston Bio Systems L - Board Meeting Outcome for Please Find Enclosed Herewith Outcome Of The Board Meeting For Year Ended 31

    30 May 2025, 4:09PM Please Find Enclosed Herewith Outcome of the Board Meeting For year ended 31st March, 2025
  • Boston Bio Systems L - Board Meeting Intimation for Consider And Approve Audited Financial Results Of The Company For The Qua

    21 May 2025, 5:03PM Boston Bio Systems Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider a
  • Boston Bio Systems L - Reg. 34 (1) Annual Report.

    16 May 2025, 3:51PM This is to inform that, pursuant to Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation of o
  • Boston Bio Systems L - Confirmation On Non-Applicability Of Disclosure Of Large Corporate For The Financial Year Ended 31St M

    14 May 2025, 10:46AM Please find enclosed herewith the Non- Applicability of Disclosure of Large Corporate for the financial year 31st March, 2025.
  • Boston Bio Systems L - Announcement under Regulation 30 (LODR)-Change in Management

    12 May 2025, 4:08PM Please find enclosed herewith pdf of Change in Management for your reference.
  • Boston Bio Systems L - Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th May, 2025

    12 May 2025, 4:04PM Please find enclosed herewith Outcome of the board meeting for your information.
  • Boston Bio Systems L - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    18 Apr 2025, 12:54PM Please find enclosed Compliance Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018 for quarter ended 31st March, 2025 for your referen
  • Boston Bio Systems L has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    18 Apr 2025, 11:50AM As of March 2025, 2.14% is owned by Indian Promoters and 97.86% by Public. <p align=justify> Top Promoter holding highest number of shares of Boston B
  • Boston Bio Systems L has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024

    28 Mar 2025, 3:20PM As of December 2024, 2.14% is owned by Indian Promoters and 97.86% by Public. <p align=justify> Top Promoter holding highest number of shares of Bosto

Key fundamentals

Evaluate the intrinsic value of Boston Bio Systems Ltd stock 

Name March-24 March-23 March-18 March-17 March-16
Assets 7.318 7.4587 7.4659 7.4656 7.4651
Liabilities 7.318 7.4587 7.4659 7.4656 7.4651
Equity 7.0022 7.0022 7.0022 7.0022 7.0022
Gross Profit -0.1407 -0.0022 0.0005 -0.0444 0.001
Net Profit -0.1407 -0.0022 0.0003 0.0005 0.0002
Cash From Operating Activities 0 -0.0012 0.1272 -0.0243 0
NPM(%) 0 0 0.04 0.1 0.01
Revenue 0 0 0.6996 0.4873 1.4962
Expenses 0.1407 0.0022 0.6991 0.5317 1.4951
ROE(%) -2.38 -0.03 0 0 0

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Boston Bio Systems Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 803.05 -0.45 26.62 4.08 301.39 0.62
Lotus Eye Hospital and Institute Ltd 72.28 0.33 205.43 14.87 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 25.50 -1.01 0.00 30.87 -39.50 0.00
Astec Lifesciences Ltd 671.00 -0.89 0.00 14.02 -687.10 0.00

Company Info

Boston Bio Systems Ltd started as ADHAYATMDEEP EYE FOUNDATION LIMITED in April, 1995 from Amhedabad. The company focused on laser eye care industry and changed the name as LASER EYE CARE LIMITED. Having duly passed the necessary resolution in terms of section 21/31/44 of the companies act. 1956 on 22/04/2002 and the approval of the central government signifies in writing having been accorded thereto by the register of companies. Gujarat vide his letter dated 15/05/2002 in terms of Government of india. Ministry of law justice & company affairs development of company affaires notification no. GSK 50/(E) dated 24/06/1985 the name of the said company is this dav changed to BOSTON BIO SYSTEMS LIMITED.

Boston Bio Systems Ltd started as ADHAYATMDEEP EYE FOUNDATION LIMITED in April, 1995 from Amhedabad. The company focused on laser eye care industry and changed the name as LASER EYE CARE LIMITED. Having duly passed the necessary resolution in terms of section 21/31/44 of the companies act. 1956 on 22/04/2002 and the approval of the central government signifies in writing having been accorded thereto by the register of companies. Gujarat vide his letter dated 15/05/2002 in terms of Government of india. Ministry of law justice & company affairs development of company affaires notification no. GSK 50/(E) dated 24/06/1985 the name of the said company is this dav changed to BOSTON BIO SYSTEMS LIMITED.

Read More

Parent Organisation

Boston Bio Systems Ltd.

Founded

17/04/1995

Managing Director

Mr.Pratik Satish Patil

NSE Symbol

FAQ

The current price of Boston Bio Systems Ltd is

The 52-week high for Boston Bio Systems Ltd is

The market capitalization of Boston Bio Systems Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Boston Bio Systems Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Boston Bio Systems Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Boston Bio Systems Ltd shares.

The CEO of Boston Bio Systems Ltd is Mr.Pratik Satish Patil, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT